Weishi rockets
(Redirected from WS-3)
Weishi Rockets[edit | edit source]
The Weishi (Chinese: 卫士; pinyin: Wèishì; "Guardian") series of multiple launch rocket systems (MLRS) are a family of artillery rocket systems developed by the People's Republic of China. These systems are designed to provide long-range fire support and are capable of launching a variety of rocket types, including guided and unguided munitions.
Development and Variants[edit | edit source]
The Weishi rocket systems were developed by the China National Precision Machinery Import and Export Corporation (CPMIEC) and have been in service since the late 20th century. The series includes several variants, each with different capabilities and specifications.
WS-1[edit | edit source]
The WS-1 was the first in the series, introduced in the 1990s. It features a range of up to 100 kilometers and is equipped with unguided rockets.
WS-2[edit | edit source]
The WS-2 is an improved version with a range of up to 200 kilometers. It can be equipped with both unguided and guided rockets, enhancing its accuracy and effectiveness.
WS-3[edit | edit source]
The WS-3 variant introduced further improvements, including a longer range and the ability to launch precision-guided munitions. This variant is designed to engage both stationary and moving targets with high precision.
WS-22[edit | edit source]
The WS-22 is a more recent addition to the Weishi family, featuring advanced guidance systems and a range of up to 300 kilometers. It is capable of launching a variety of warheads, including cluster munitions and high-explosive rounds.
Operational Use[edit | edit source]
The Weishi rocket systems are used by several countries around the world, primarily for their long-range artillery capabilities. They are particularly valued for their ability to deliver a large volume of firepower over a wide area, making them effective in both offensive and defensive operations.
International Operators[edit | edit source]
Countries known to operate Weishi rocket systems include China, Bangladesh, and several others in Asia and the Middle East. These systems have been exported to various nations, enhancing their artillery capabilities.
Tactical and Strategic Impact[edit | edit source]
The introduction of the Weishi series has significantly impacted the tactical and strategic landscape of artillery warfare. Their long range and precision capabilities allow for effective engagement of enemy forces from a safe distance, reducing the risk to friendly units.
Related Pages[edit | edit source]
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD